Vaxcyte
PCVX
66.96
+0.26
+0.39%
Vaxcyte
US · PCVX
#1630 by market cap
Listed 2020
66.96
+0.26
+0.39%
Live - 5344 symbols - heartbeat 114s ago
· 2026-10-08 07:36
Pre-market
66.78
-0.27%
After-hours
66.60
-0.54%
Overnight
66.59
-0.55%
- Market cap
- 9.96B
- P/E (TTM)i
- -8.78
- P/Bi
- 3.61
- EPSi
- -5.63
- Div yieldi
- 0.00%
- 52W posi
- 53%
Reader sentiment
Are you bullish or bearish on PCVX?
Anonymous reader poll. Unscientific, not investment advice.
Analyst consensus 7 analysts
Buy
Avg price target
120.00 +79.2%
Price target rangecurrent 66.96
Low75.00
Avg120.00
High163.00
Buy 100%
Hold 0%
Sell 0%
Recent ratings (25)
| Date | Firm | Analyst | Rating | Target |
|---|---|---|---|---|
| 2026-10-05 | Mizuho Securities | -- | BUY | 163.00 |
| 2026-10-05 | Jefferies | -- | BUY | 146.00 |
| 2026-10-05 | Needham | -- | BUY | 122.00 |
| 2026-10-05 | Guggenheim | -- | BUY | 125.00 |
| 2026-09-28 | BofA Securities | -- | BUY | -- |
| 2026-09-25 | Needham | -- | BUY | 110.00 |
| 2026-08-06 | Needham | -- | BUY | 110.00 |
| 2026-08-05 | TD Cowen | -- | BUY | 75.00 |
| 2026-08-05 | BofA Securities | -- | BUY | 133.00 |
| 2026-08-05 | Guggenheim | -- | BUY | 116.00 |
| 2026-07-29 | BTIG | -- | BUY | 89.00 |
| 2026-06-26 | Needham | -- | BUY | 110.00 |
| 2026-06-18 | Mizuho Securities | -- | BUY | 163.00 |
| 2026-06-02 | Mizuho Securities | -- | BUY | 163.00 |
| 2026-05-21 | Evercore | -- | BUY | -- |
| 2026-05-07 | BofA Securities | -- | BUY | -- |
| 2026-05-07 | Needham | -- | BUY | 110.00 |
| 2026-05-06 | TD Cowen | -- | BUY | 75.00 |
| 2026-04-15 | Needham | -- | BUY | 110.00 |
| 2026-03-02 | BTIG | -- | BUY | 89.00 |
| 2026-02-26 | Goldman Sachs | -- | HOLD | 67.00 |
| 2026-02-26 | Guggenheim | -- | BUY | 116.00 |
| 2026-02-25 | TD Cowen | -- | BUY | 75.00 |
| 2026-02-25 | BTIG | -- | BUY | 89.00 |
| 2026-02-25 | BofA Securities | -- | BUY | 133.00 |
Quant vs Street three independent views, side by side
Momentum strategy signal
Buy
Analyst consensus
Buy
All 2 views agree: bullish.
Not investment advice. The factor grade ranks this stock on fundamentals against StockVane's covered universe; the momentum strategy signal is a rules-based backtest, not a recommendation; analyst consensus reflects sell-side coverage. The three use different methods and can reasonably disagree.
Price target trend monthly average, last 3 years
Earnings history price reaction on the day
| Period | Report date | Session | Options expected | Actual move |
|---|---|---|---|---|
| 2025/Q4 | 2026-02-24 | After close | ±9.54% | +2.75% (in line) |
| 2024/Q4 | 2025-02-25 | After close | ±17.57% | -0.88% (in line) |
| 2023/Q4 | 2024-02-27 | After close | ±12.24% | -7.33% (in line) |
| 2022/Q4 | 2023-02-27 | After close | ±15.57% | -3.14% (in line) |
| 2021/Q4 | 2022-02-28 | -- | ±15.02% | +2.52% (in line) |
| 2020/Q4 | 2021-03-29 | -- | -- | -4.34% |
"Options expected" is the pre-earnings options market's implied move (a straddle-style estimate), shown next to what actually happened.
Quote time 2026-10-08 07:36:37 · For reference only, not investment advice and not tailored to your situation.